Gilead's remdesivir wins FDA's first full approval against Covid
The drug, branded as Veklury, won emergency use authorization from the FDA in early May.
Full Article
Gilead's remdesivir wins FDA's first full approval against Covid
bizjournals
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: ElectraMeccanica Vehicles, Willow Biosciences, DRDGOLD Limited, Aurania Resources UPDATE ...
Proactive Investors
ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) announced Thursday that an initial shipment of production SOLO electric vehicles have..
-
NA Proactive news snapshot: DGTL Holdings, First Cobalt, American Resources, Progressive Planet, Silver Range Resources, African Gold Group UPDATE...
Proactive Investors
-
Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
Esports Entertainment Group, Inc. (NASDAQ:GMBL), the online esports tournament and gaming company, has signed a deal valued at..
-
Biotech Stocks Facing FDA Decision In November 2020
RTTNews
-
US stocks end mixed as investors weigh coronavirus stimulus package negotiations
Proactive Investors
-
US indices hit a snag as traders eye economic data and potential stimulus package agreement
Proactive Investors
-
US benchmarks start mixed as traders eye economic data and potential stimulus package agreement
Proactive Investors